Vaccination centers throughout Ukraine have used almost all of the AstraZeneca (Covishield and SKBio) Covid-19 vaccines intended for immunization with the first dose. This was reported by the press service of the Ministry of Health.
Part of this vaccine, a total of 26,000 doses, is reserved for the administration of a second dose to those patients whose vaccinations began on Feb. 24.
"In May, some people who were vaccinated with the first dose of the AstraZeneca / Covishield vaccine against Covid-19 will begin to receive the second dose (12 weeks after the first vaccination). For this, 26,000 doses of the AstraZeneca-SKBio vaccine have been reserved," the statement said.
As we reported earlier, the European Commission refused to renew the contract for the supply of the British-Swedish vaccine AstraZeneca in the second half of this year. The relevant information was confirmed by the European Commissioner for Internal Market Thierry Breton.
This decision was made by the EU against the backdrop of claims against the manufacturing company, which turned into a lawsuit. The European Union announces the disruption of the supply of the AstraZeneca vaccine.